Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

JHSPE. 2024; 4(1): 59-61


AMOXICILLIN+ CLAVULANIC ACID INDUCED TOXIC EPIDERMAL NECROLYSIS (TEN)

Hiren Jitendra Udhnawala,Hitesh Baldevbhai Chaudhari,Alpa Gor.




Abstract
Cited by 0 Articles

Amoxicillin, an antibiotic with broad-spectrum bactericidal properties and beta-lactam structure, demonstrates efficacy in treating various infections. Commonly reported adverse reactions include skin rashes and urticaria (3%), vomiting (1%), nausea (3%), diarrhea/loose stools (9%), and vaginitis (1%). According to statistics from the FDA, less than 3% of patients ceased therapy as a result of adverse reactions to their prescribed medications. "The predominant adverse effects linked to penicillin use predominantly involve hypersensitivity responses. Post-marketing surveys have revealed instances of exfoliative dermatitis, including erythema multiforme, pruritus, toxic epidermal necrolysis (TEN), serum sickness-like reactions (urticaria or skin rash accompanied by myalgia, arthritis, fever, and arthralgia), and angioedema." In order to reduce the risks associated with drug use and improve patient safety and welfare, the Pharmacovigilance Program of India (PvPI) was established. The Department of Pharmacology at Pramukh Swami Medical College in Karamsad is one of the ADR Monitoring Centers (AMCs), gathering ADRs as well as case studies and series to inform the public about rare adverse reactions of certain drugs. This case report gives details of a 72 year old Male who developed TEN following the use of the Fixed Dose Combination of Amoxicillin (500mg) + Clavulanic acid (125mg) to treat infection for the epididymo-orchitis. This case report adds and increases need for awareness of rare but serious side effects of Amoxicillin+ Clavulanic acid The report emphasizes on the active ADR monitoring of drugs which may cause serious side effects like TEN

Key words: Amoxicillin ,Clavulanic acid, Toxic epidermal necrolysis






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.